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ABSTRACT 
 
Mannose and Lipopolysaccharide Receptors on the Surface of Granular Hemocytes from the 
Crayfish Procambarus clarkii  
by 
Gelu Dobrescu 
 
Procambarus clarkii hemocytes have been shown to bind to both LPS and a mannose containing 
neoglycoprotein conjugated to fluorescent probes.  A decrease in the observed number of 
fluorescent hemocytes indirectly indicated that the binding of FITC-LPS to these cells is 
impaired by initial incubation with LPS.  Prior treatment of hemocytes with horseradish 
peroxidase, a mannose rich glycoprotein, decreased their capacity to bind mannose.  Mannan had 
no inhibitory effect on the binding of either ligand.  Mixed hemocytes and hemocyte 
subpopulations separated by buoyant density were incubated with both ligands and revealed that 
a subpopulation of granular hemocytes bound both LPS and mannose.  These results suggest the 
possible presence of 2 different pattern recognition cell surface receptors on this subpopulation 
of granular hemocytes from the red swamp crayfish, Procambarus clarkii, which may 
specifically recognize and bind to both LPS from gram-negative bacteria and to mannose 
containing glycoproteins found on microbial surfaces.   
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DEDICATION 
I dedicate this work to the splendid and complex underlying principle of molecular 
recognition that is involved in the discrimination between “self” and “non-self” by the immune 
responses of all living organisms, and to the molecular conflict and/or symbiosis that occur 
following recognition.  Let us remember that for various reasons the distinction between “self” 
and “non-self” can and sometimes does become blurry, but that conflict need not remain a 
constant of life.  
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CHAPTER 1 
INTRODUCTION 
 
 Cellular and humoral pattern recognition molecules of vertebrates and invertebrates 
initiate several kinds of innate defense mechanisms after specific recognition of 
lipopolysaccharides (LPS or endotoxin) and peptidoglycans from bacteria, and β-1,3-glucans 
from fungi (1).  Vertebrate pattern recognition molecules also specifically recognize and bind to 
endogenous and exogenous mannose-terminating glycoproteins and peptides (2).  These 
recognition proteins and their receptors belong to the lectin superfamily (i.e. sugar binding 
proteins) and are coupled to effector functions, such as complement activation in mammals (2) 
and prophenoloxidase system (proPO) activation in invertebrates (1).  These functions activate 
the cellular and humoral components of the immune system to provide biological defense for the 
animal (1,2,3).  Depleted levels of lectins have been shown to predispose mammals to severe and 
recurrent infections (4,5).       
In the case of humans and other vertebrates, the structurally conserved lipid A portion of 
smooth (S) or rough (R) form lipopolysaccharide (LPS), from intact gram-negative bacteria or 
that released by bacteria into serum, is bound with high stoichiometric affinity by a soluble 60-
kD carrier acute-phase glycoprotein, the LPS-binding protein (LBP) (6,7).  The LPS-LBP 
complex then binds to leukocytes through a 55-kD glycoprotein receptor, the monocytic 
differentiation antigen CD14.  CD14 is attached to the eukaryotic membrane via a 
phosphatidylinositol glycan anchor and is mobile in the plane of the membrane.  After specific 
binding to LPS or LBP, CD14 is responsible for the signal transducing events leading to cell 
activation (8).  LPS in the presence of LBP is more effective than LPS alone in activating 
leukocytes (6).   Activated monocytes and macrophages respond to LPS at nanogram per 
milliliter concentrations by inducing the secretion of lipid products of arachidonic acid, toxic 
oxygen radicals, and cytokines, such as tumor necrosis factor-α (TNF-α).  The cellular 
expression of intercellular adhesion molecules (ICAM-1) and induction of enzymes involved in 
the synthesis of small proinflamatory mediators are also enhanced (1).  Polyclonal antibodies 
against LBP (anti-LBP) immunoprecipitated R and S form LPS from LPS mixtures and normal 
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mammalian plasma. Immunodepletion of LBP from normal plasma, with anti-LBP polyclonal 
goat immunoglobulin G (IgG), resulted in inhibition of R and S form LPS-induced TNF-α 
production by rabbit leukocytes (7).  Furthermore, a blockade of anti-CD14 monoclonal 
antibodies was shown to down-modulate the binding to CD14 of sheep erythrocytes coated with 
LPS-LBP complexes and to block the LPS-stimulated synthesis of TNF-α (8).    
In addition, human mononuclear phagocytes and murine macrophages possess a 
membrane receptor, composed of 2 disulfide-linked polypeptide chains, that has ligand 
specificity for the β-glucans commonly found in yeast and fungi.  This receptor initiates the 
phagocytosis of these organisms in the absence of opsonins (9).    
The vertebrate mannose receptor, also referred to as the mannose-fucose receptor, is 
present on the surface of mononuclear phagocytes (macrophages and denditric cells) and on non-
immune cells, such as hepatic endothelial cells, kidney glomeruli cells, and tracheal smooth 
muscle cells (2,3,5).  It is a type I transmembrane glycoprotein (165-kD).  Its extracellular 
domain consists of 8 different Ca2++-dependent (C-type) carbohydrate recognition domains 
(CRDs), a fibronectin type II repeat, and a cysteine rich segment (10).  The 8 CRDs are 
responsible for recognition of and high affinity binding to different molecular patterns (11).  
Stahl et al. (12) have shown that the rate at which β-glucuronidase (a lysosomal glycosidase) is 
cleared from rat plasma sharply decreases when fucose- (Fuc), mannose- (Man), N-acetyl-D-
glucosamine- (GlcNac), and xylose- (Xyl) coupled to bovine serum albumin (neoglycoproteins) 
are simultaneously administered.  The following order of decreasing affinity for the mannose 
receptor has been established: L-Fuc = D-Man > GlcNac ≅ D-glucose > D-Xyl > > > D-galactose 
= L-arabinose = D-Fuc.  These molecules are both ligands and inhibitors of the mannose 
receptor, and they are the terminal oligosaccharides of glycoproteins and peptides frequently 
found on the surfaces of microorganisms.   
Several glycoproteins, including horseradish peroxidase and mannan, have been shown to 
serve as ligands and to effectively inhibit ligand binding by the mannose receptor (13).  
Horseradish peroxidase has an 86% carbohydrate content, and it consists predominantly of 
mannose and glucosamine and lesser and varying amounts of fucose, xylose, and arabinose (14).  
The principal antigen of yeast is its cell wall mannan component.  Mannan is composed almost 
entirely (50-90%) of highly branched poly-D-mannose chains that have 1→2, 1→3, and 1→6 
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linkages between the sugar units (15).  Macrophage uptake of β-glucuronidase is nearly 
completely inhibited when excess yeast mannan is simultaneously administered (12).                        
The mannose binding protein (MBP) is a soluble acute phase protein.  It consists of both 
lectin and collagen domains, which are organized as bouquets containing 2 to 6 building blocks 
with 3 terminal CRDs (2). It functions as an opsonin, modulates the host inflammatory response 
to infections and enhances the uptake of MBP-pathogen complexes via the mannose receptor.  
MBP displays ligand affinity and specificity similar to that of the mannose receptor (3,4), 
including specific binding to some strains of LPS (11).  The structure and composition of 
bacterial endotoxins have a major influence on MBP and mannose receptor binding.  For 
instance, MBP was shown to bind specifically to the nonreducing terminal N-acetyl-D-
glucosamine and D-mannoheptose residues present in the rough outer core polysaccharide of 
Salmonella Ra chemotype LPS but not to smooth Re chemotype LPS (4).  The binding of MBP 
to these carbohydrate residues of LPS activates the complement cascade in an antibody and C1q 
independent manner (4,16).  The structures of smooth and Re chemotype endotoxin mask the 
mannose (when present) and N-acetyl-D-glucosamine residues.  They also alter the sugar density 
or conformation of the LPS molecules in order to prevent lectin ligation (4).                
The mannose receptor mediates macrophage phagocytosis of unopsonized and opsonized 
bacteria (Escherichia coli, Pseudomonas aeruginosa, Mycobacterium tuberculosis), fungi 
(Candida albicans, Pneomocystis carinii) and some enveloped viruses (human 
immunodeficiency virus type 1, influenza A) in the vertebrate innate immune response (3,4).  It 
is also responsible for the endocytic clearance of endogenous soluble proteins that bear high-
mannose oligosaccharides (i.e. lysosomal enzymes and tissue plasminogen activator) (4).  
Further downstream events that have also been coupled to the interactions between the mannose 
receptor and its ligands include: the release of lysosomal enzymes, reactive oxygen 
intermediates, arachidonic acid metabolites, and cytokines (IL-1, IL-6, IL-12, GM-CSF, TNF-α), 
and the efficient delivery of captured antigens to major histocompatability complex (MHC) 
Class II-containing compartments.  These functions indicate the existence of signal transducing 
ability and possible receptor roles in facilitating antigen uptake, processing, and presentation in 
the adaptive immune response of vertebrates.  The mannose receptor may represent a link 
between innate and adaptive immunity (4).     
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Invertebrate animals, such as the crayfish Procambarus clarkii, mount extremely 
efficient cellular and humoral innate immune responses against invading pathogens and “non-
self” molecules present in their freshwater environments (17).  However, they lack an adaptive 
immune system and, hence, production of antigen specific antibodies (18).  Despite the structural 
and chemical barrier formed by the hard exoskeleton in these animals, invading parasites and 
pathogenic and non-pathogenic microorganisms can enter the body cavity through a wounded 
cuticle, through the alimentary canal, or during the molt and establish an active infection 
(1,17,18,19,20).  Their cellular defense mechanisms reside in the activities of circulating 
hemocytes (17).  These cells participate in phagocytosis, encapsulation or nodule formation, and 
synthesis and exocytosis of the clotting cascade, the prophenoloxidase-activating system, and 
other antibacterial proteins and peptides (1).  They also participate in nutrient transport and 
waste removal throughout the body (21).  Three distinct populations of hemocytes have been 
isolated, separated, and morphologically described under electron and phase contrast microscopy 
(22,23,24).  Their relative behavior and function in vitro have been partially clarified (23,24).  
All 3 hemocyte populations attach to the glass surface of coverslips within 20 minutes (24).     
The hyaline cells are the most abundant hemocyte type (about 75-77%) (22).  They have 
a hyaline cytoplasm with flat pseudopodia extending from a pleomorphic surface, contain no 
granules, and have a high nucleo-cytoplasmic ratio (17,22).  Hyaline hemocytes are phagocytic 
(17).  Semigranular cells are ovoid or fusiform in shape, are present in low numbers (about 8-
9%), have a low nucleo-cytoplasmic ratio, and contain a variable number of small, round, or 
slightly oval granules that appear eosinophillic when stained with Wrights stain (22).  According 
to Soderhall et al. (17,24), semigranular hemocytes display limited phagocytic ability.  However, 
they are the principal cells involved in encapsulation reactions, and the only cells to specifically 
degranulate in response to direct exposure to lipopolysaccharides and β-1,3-glucans (17).  
Granular cells demonstrate mainly spherical shapes, have low nucleo-cytoplasmic ratio, are more 
numerous than semigranular hemocytes (15-16%), and contain large granules (17,24).  Granular 
hemocytes are not phagocytic.  Their granules, like those of the semigranular cells, are 
repositories for the prophenoloxidase activating system (proPO system) (19).  They undergo 
exocytototic release only when triggered by an endogenous 76 kD factor and an endogenous β-
1,3-glucan binding protein previously exposed to β-1,3-glucans (17, 19).  
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Several invertebrate pattern recognition molecules have been found and partially 
characterized, although the exact nature of their interactions with antigen is not yet known.  For 
instance, Yashida and coworkers (25) purified and described a unique, single chain 19kDa 
hemolymph protein from the silkworm Bombyx mori.  This defense protein binds with high 
affinity to molecules of peptidoglycan and triggers the release and activation of the proPO 
cascade (1, 25).  In the horseshoe crab Tachypleus tridentatus, LPS and β-1,3-glucans bind to 
factors C and G, respectively, and initiate the hemolymph clotting cascade.  Both proteins are 
intracellular serine protease zymogens.  They undergo conformational changes and are 
autocatalytically converted to their biologically active forms following antigen ligation (26).  
Interestingly, factor C contains vertebrate complement domains, suggesting that invertebrates 
also possess complement-like factors for defense (27).             
Furthermore, a β-1,3-glucan binding protein (βGBP), a β-1,3-glucan-binding- protein 
membrane receptor, and a LPS and β-1,3-glucan binding protein (LGBP) from the freshwater 
crayfish Pacifastacus leniusculus have been purified and described (1,28).  βGBP is a 
monomeric plasma glycoprotein of 100kDa.  It becomes activated after reacting to β-1,3-
glucans, but not to mannans, undergoes a conformational change, and binds to the specific β-1,3-
glucan-binding-protein hemocyte membrane-receptor (1).  This is the only receptor that has so 
far been purified from invertebrate hemocytes, and it consists of 2 non-covalently associated 
polypeptide subunits of 230 kDa and 90 kDa (28).  Its ligation to βGBP induces the exocytotic 
release of an inactive proPO system and of LGBP (1).   
The mature LGBP consists of 346 amino acid residues and has a molecular mass of 36 
kD and 40 kD on 10% SDS-polyacrylamide gel electrophoresis under reducing and nonreducing 
conditions, respectively.  LGBP binds specifically to LPS and β-1,3-glucans (i.e. laminarin, 
curdlan), but not to peptidoglycan, and activates the released proPO.  A blockade of anti-LGBP 
antibodies significantly inhibits the phenoloxidase activity of hemocyte lysate.  LGBP shows 
significant amino acid sequence homology with several previously reported invertebrate Gram-
negative bacteria-binding proteins and β-1,3-glucanases (1).   
All these endogenous invertebrate proteins recognize antigenic molecules, mediate the 
attachment between hemocyte surfaces and “non-self” entities in the hemolymph, and activate 
the host cellular and humoral immune responses (17).  In particular, low concentrations of 
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microbes or microbial molecules in the hemolymph are phagocytized by hyaline hemocytes and, 
to a limited extent, by semigranular hemocytes  (17, 18).  When higher concentrations are 
present, increasing numbers of semigranular cells aggregate on and around the foreign particles.  
These aggregates form capsules consisting of densely packed hemocyte layers, which entrap and 
seal off the intruders from the circulation (29).  Concomitant degranulation of semigranular and 
granular hemocytes also occurs (17,18,29).        
Throughout the animal kingdom, this receptor-mediated exocytotic release of proteins 
from cellular vesicles in response to various stimuli is a fundamental process (30).  The 
exocytosis of granular contents from hemocytes into the external milieu in response to 
endotoxin, peptidoglycans, and β-1,3-glucans confers humoral immunity to invertebrates (17).  
For instance, the clotting cascade, the proPO-activating system, and a broad spectrum of 
antibacterial proteins and peptides are released into the plasma and are activated (1,17,24).  
These invertebrate humoral immune components act in concert with the cellular immune 
functions of phagocytosis and encapsulation (17).  This interplay leads to a strong host defense 
mechanism (17) and a short-lived increased resistance to certain pathogens following prior 
exposure to them or their cell wall polysaccharides (31).   
Once released from the hemocytes, the complete activation of the clotting cascade 
induces coagulogen molecules (also sequestered in and released from hemocyte granules) to 
polymerize like vertebrate fibrinogen and form the coagulin gel (26).  The coagulin gel is an 
insoluble clot that seals wounds and entraps parasites (17,26).   
The proPO system is also activated after its exocytotic release.  ProPO-activating 
enzymes (endogenous serine proteases) proteolytically cleave prophenoloxidase and convert it to 
the biologically active phenoloxidase (monophenyl L-dopa: oxygen oxidoreductase) (19, 24).  
This redox enzyme is the terminal component of the proPO system.  Phenoloxidase crosslinks 
LPS to a still unidentified LPS receptor on the hemocyte surface, and it catalyzes the oxidation 
of phenols to quinones (17).   Quinones then undergo several nonenzymatic polymerization steps 
and form melanin (1,17,32).  This final product melanizes (blackens) pathogens, including those 
already entrapped by the coagulin gel and the encapsulation reaction, hardens the cuticle, and 
heals wounds (1,17).  Melanin and its intermediates, such as 3,4-dihydroxyphenylalanine and 
hydrogen peroxide, are also highly reactive compounds that can prevent growth of bacteria and 
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some fungi by inhibiting their extracellular proteinases and chitinases (32).  Furthermore, the 76 
kD factor (an opsonin) and the β-1,3-glucan binding protein, both components of the proPO 
system, have been shown to participate in intercellular communication by functioning as cell 
adhesion factors.  They trigger adjacent hemocytes to adhere to and encapsulate the foreign 
particles and to degranulate, thereby amplifying the invertebrate cellular and humoral immune 
responses (17).   
Still unidentified components of the proPO system also appear to increase the phagocytic 
rate of hyaline hemocytes and to be involved in the clotting cascade.  The proPO cascade is, 
therefore, the centerpiece of internal defense in crustaceans (33).  It resembles the vertebrate 
complement cascade because it produces fungistatic, opsonic, lytic, and degranulating factors 
(34).  However, unlike vertebrate complement, the proPO cascade is localized within the 
secretory vesicles of semigranular and, above all, granular cells (19,34).        
Other hemocyte components with potent antimicrobial properties are also exocytotically 
released from invertebrate circulating hemocytes along with the proPO system (17, 32).  These 
include the tachyplesin cationic peptides, which even at low concentrations nonspecifically 
permeabilize bacterial and fungal membranes and cause irreversible loss of viability (26).  
Because the production of antimicrobial peptides occurs within a few hours after the entry of a 
bacterium or fungus, some sort of signal transduction must occur following receptor ligation of 
the antigen (32).  Interestingly, the mature tachyplesin peptides are stored within granules, just as 
mammalian cationic antibacterial peptides (i.e. defensins) are sequestered within the azurophilic 
granules of neutrophils (26, 35).  
Pattern recognition molecules of innate immunity recognize, localize, and help to 
neutralize microbial invaders (2).  In mammals, the response to an infectious challenge consists 
of a reciprocal interplay between innate and adaptive immunity, and this interplay leads to a 
systemic state of increased resistance to invading pathogens (3).  Although invertebrates lack 
adaptive immunity (17), a thorough understanding of innate immune mechanisms is necessary 
because a disruption in innate immunity can adversely affect antigen specific adaptive responses 
in higher animals (3).  So far, only the hemocyte membrane receptor with specificity for βGBP 
has been identified in invertebrates (28). The overall aim of the work presented here was to 
establish the possible presence of LPS and mannose receptors on the surface of distinct 
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subpopulations of circulating hemocytes from the red swamp crayfish Procabarus clarkii.  This 
is apparently the first report to provide evidence for the presence and localization of these 
receptors in the granular hemocytes of this invertebrate species.     
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CHAPTER 2 
MATERIALS AND METHODS 
 
Animals 
Red swamp crayfish, Procambarus clarkii, were purchased from Waubun 
Laboratories, Inc. (Shriever, LA) through Carolina Biological Supply, Co. (Burlington, N.C.), 
maintained in aerated freshwater aquaria at 25°C, and fed every 3 to 4 days with guinea pig 
pellets (The Hartz Mountain Corporation, Secaucus, NJ).  Only apparently healthy intermoult 
adult crayfish were used in these experiments.  Prior to bleeding, all animals were anesthetized 
in ice water for approximately 5 minutes. 
 
Preparation of Reagents and Serial Dilutions 
 Reconstitutions and serial dilutions of ligands and inhibitors were made in sterile 0.15M 
NaCl dissolved in double distilled water, using sterile polypropylene pipette tips and sterile, 
nonpyrogenic, 5ml disposable 12x75mm polysterene round-bottom tubes (Fisher Scientific, 
Pittsburgh, PA).  The following mixtures were made, and each solution was vigorously vortexed 
before transfer and experimental use to ensure homogeneity.  
 
Fluorescein Isothiocyanate-Lipopolysaccharide 
One mg of lyophilized and chromatographically purified powder of fluorescein 
isothiocyanate-lipopolysaccharide (FITC-LPS) was obtained from Sigma Chemical Company, 
St. Louis, MO.  It was prepared from the smooth lipopolysaccharide of E. coli, serotype 
0111:B4, and it contained 2-10µg FITC per mg LPS.  The FITC-LPS powder was reconstituted 
and serially diluted to concentrations of 1.0, 2.5, 5.0, 10.0, 15.0, and 20.0 µg ml-1 FITC-LPS. 
 
Streptavidin-FITC  
One ml of Streptavidin-FITC (SFITC) was purchased from Southern Biotechnology 
Associate, Inc., Birmingham, AL.  It was serially diluted in sterile 0.15M NaCl to concentrations 
of 1.0, 2.5, 5.0, 10.0, 15.0, and 20.0 µg ml-1 SFITC.  
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Avidin-Rhodamine Isothiocyanate  
One mg of lyophilized powder of avidin-rhodamine isothiocyanate (ARITC) was 
obtained from Sigma Chemical Company, St. Louis, MO.  It contained 1-2 moles of rhodamine 
isothiocyanate per mole of avidin.  The ARITC powder was reconstituted and serially diluted to 
concentrations of 1.0, 2.5, 5.0, 10.0, 15.0, and 20.0 µg ml-1 ARITC. 
 
Bovine Albumin, Fraction V  
One point six mg fraction V of bovine albumin (BSA) was obtained from Sigma 
Chemical Company, St. Louis, MO.  It was reconstituted and diluted to a concentration of 1µg 
ml-1 BSA conjugate. 
 
Bovine Albumin-α-D-Mannopyranosylphenyl Isothiocyanate-Biotin Labeled 
One mg of lyophilized powder of bovine albumin-α-D-mannopyranosylphenyl 
isothiocyanate-biotin labeled (MBSA-biotin) was obtained from Sigma Chemical Company, St. 
Louis, MO.  It contained 15-20 moles α-D-mannopyranose and 1.5-3.0 moles flurescein per 
mole albumin.  The powder was reconstituted and diluted to a concentration of 1µg ml-1 MBSA-
biotin.  
 
Lipopolysaccharide  
One mg of detoxified, lyophilized and chromatographically purified powder from the 
smooth lipolysaccharide (LPS) of E. coli, serotype 0111:B4, was obtained from Sigma Chemical 
Company, St. Louis, MO.  The LPS powder was reconstituted and serially diluted to 
concentrations of 1.0, 2.5, 5.0, 10.0, 15.0, and 20.0 µg ml-1 LPS. 
 
Mannan 
Ten mg of mannan powder from Saccharomyces cerevisiae was obtained from Sigma 
Chemical Company, St. Louis, MO.  The mannan powder was reconstituted and serially diluted 
to concentrations of 125, 100, 50, 25, 10, and 1 µg ml-1 mannan.  Higher serial dilutions of 100, 
10, and 1 ng ml-1, and 100 pg ml-1 mannan were also made.  
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Horseradish Peroxidase Type XI 
Lyophilized powder of peroxidase (apoperoxidase) from horseradish (HRP) was obtained 
from Sigma Chemical Company, St. Louis, MO.  It was reconstituted and serially diluted to 
concentrations of 100, 50, 25, 10, and 1 µg ml-1 HRP.  
 
Bleeding and Preparation of Hemocytes 
 Hemolymph was withdrawn from individual crayfish (2 to 3 animals for receptor binding 
and inhibition assays; 5 to 7 animals for the Percoll discontinuous gradients) by puncturing the 
abdominal hemocoel with a 22 gauge sterile needle.  The hemolymph was collected into a 3 cc 
sterile syringe (Fisher Scientific, Pittsburgh, PA), containing 0.5 ml of citrate/EDTA crayfish 
anticoagulant buffer of pH 4.6 (23, see Appendix).  The crayfish anticoagulant buffer was 
precooled at 4°C.  Citric acid in the anticoagulant buffer delayed cell break down, while EDTA 
inhibited the activation of the clotting and prophenoloxidase cascades (23).  The hemolymph 
expressed from individual syringes was pooled into a sterile 15 ml disposable centrifuge tube 
(Fisher Scientific, Pittsburgh, PA), and it was mixed with a sterile Pasteur pipette.  A small 
aliquot (~ 150 µl) was removed, and a 0.100-millimeter deep Neubauer Brightline 
hemocytometer (Hausser Scientific) was used to determine total hemocyte counts in the 
hemolymph by examination under phase contrast optics (400x objective lens) of an Olympus 
BH-2-RFCA microscope (Olympus Optical Co., LTD, Japan).  If the hemolymph contained 
bacterial contamination, it was discarded.  If it did not, it was centrifuged in a swinging bucket 
centrifuge (IEC CENTRA-8R) for 10 minutes at 1,200 x g at 10°C.  The supernatant, containing 
hemolymph and anticoagulant, was discarded.  The hemocyte pellet was resuspended by mixing 
with a sterile Pasteur pipette x 20 in sterile TNM-FH insect medium (see Appendix), which was 
obtained from Sigma Chemical Company, St. Louis, MO.  Before performing further 
experimental procedures, a small aliquot (~ 150 µl) was again removed, and total hemocyte 
counts were determined using the Neubauer Brightline hemocytometer.  The hemocyte 
suspension, if necessary, was further diluted in TNM-FH insect medium to achieve a 
concentration of between 4.0 to 7.0 x 106 cells ml-1. 
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 For each assay, duplicate, 22 x 22 mm, clean and pyrogen-free glass coverslips (baked 
for at least 4 hours at 200°C to inactivate endotoxin) were placed on the bottom of clean and 
95% ethanol treated polystyrene multiwell (6-well, flat bottom) tissue culture plates (Fisher 
Scientific, Pittsburgh, PA).  Two drops of homogenous hemocyte suspension were dispensed 
with a sterile Pasteur pipette onto the middle of each coverslip surface.  The cells were allowed 
to adhere to the glass coverslips by incubation at 20°C for 30 minutes.  The cells were washed 10 
times in 3 changes of sterile and nonpyrogenic crayfish saline, which is a balanced salt solution 
that resembles the ionic composition of Astacus astacus hemolymph (24, see Appendix).  The 
cells were fixed in 100% methanol for 2 minutes at 25°C, and they were washed again 10 times 
in 3 changes of sterile crayfish saline.  All hemocytes for inhibition and standard binding assays 
were prepared and fixed in this manner prior to further experimental procedures.    
 
Standard Ligand Binding Assays for Potential LPS and Mannose Receptors 
Fixed hemocytes were incubated for 30 minutes at room temperature with FITC-LPS as 
ligand for potential LPS receptors.  Fixed hemocytes were also incubated for 30 minutes with 
MBSA-biotin (1 µg ml-1) as ligand for potential mannose receptors.  The MBSA-labeled 
hemocytes were further incubated for 30 minutes with the SFITC and/or ARITC exogenous 
fluorescent probes.  For the initial standardization assays, the concentrations of FITC-LPS, 
SFITC and ARITC varied over a wide range in order to ascertain the best concentration required 
for binding to hemocytes.  The best concentrations of those tested were used thereafter in every 
experiment.  The control for FITC-LPS consisted of 0.15M NaCl; for streptavidin-FITC and/or 
ARITC, it consisted of incubation with 1 µg ml-1 of BSA conjugate, followed by incubation with 
SFITC and/or ARITC.  Each assay condition was tested in duplicates. 
All ligands and reagents were dispensed with an individual sterile Pasteur pipette directly 
onto each coverslip surface that contained adhered and methanol fixed hemocytes.  They 
completely covered the cells and the coverslip surface.  After the reactions were allowed to 
proceed for 30 minutes at room temperature and in the dark, the cells were washed 10 times in 3 
changes of sterile and nonpyrogenic crayfish saline to remove unbound ligand or label.   
At the end of each experiment, the coverslips were mounted face down on glass slides 
using immunofluorescence mounting medium (36, see Appendix).  Ten random fields were 
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scanned (or at least 1000 cells at random), and the hemocytes were visualized and counted using 
phase contrast and fluorescence microscopy (490 nm excitation and 520 nm emission 
wavelengths for FITC, and 541 nm excitation and 572 nm emission wavelengths for ARITC) 
with 400x magnification.  The percentage of fluorescent cells was calculated from the total 
hemocytes counted.  The positive percentages are shown for each assay condition along with the 
mean of the three parallel experiments + standard error of the mean (S.E.M.).  With the 
exception of the standardization binding assays, all experiments have been performed 3 times.             
     
Inhibition of Ligand Binding to Hemocytes 
 The inhibition assays were performed under similar conditions as the standard assays.  
However, the concentrations of the LPS, mannan, and horseradish peroxidase inhibitors varied 
over a large range, while, in the next steps of the protocol, the concentrations of ligand and label 
(when applicable) remained constant.  The inhibitor was dispensed with a sterile Pasteur pipette 
directly onto each coverslip surface, and it completely covered the cells and the coverslip 
surface.  After incubation for 30 minutes in the dark at room temperature (25°C) and prior to 
ligand presentation in the standard binding assays, the cells were washed as in the standard 
protocol.   
The percentage of fluorescent cells was calculated from the total hemocytes counted.  
The positive percentages are shown for each assay condition along with the mean of the 3 
parallel experiments + standard error of the mean (S.E.M.).  Analysis of statistical differences for 
the inhibition assays, in a series of 3 experiments, were made by comparing the mean percent of 
fluorescent hemocytes obtained for each inhibitor concentration used with that of the control that 
was not presented with the inhibitory ligand.  The means are significantly different at p < 0.05 
(paired t test).  
Normality check and 2-way analysis of variance (2-way ANOVA), followed by the least 
significant difference (LSD) multiple comparisons test, were performed and interpreted for the 
inhibition studies that used LPS to prevent the binding of FITC-LPS to hemocytes.  The LSD 
multiple comparisons test revealed that the groups are significantly different if the difference 
between group means is greater than the LSD value.  An F-ratio >> 1and a p value < 0.05 also 
indicated significant difference among group means.      
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Preparation of Gradients and Enrichment of Hemocyte Subpopulations 
 The Percoll gradient was initially calibrated using density marker beads (Sigma Chemical 
Company, St. Louis, MO).  The different hemocyte subpopulations of P. clarkii were isolated 
and enriched using a modification of a standard technique, which was previously reported for 
marine and freshwater crustaceans (23,24).  A 40%, 50%, and 60% discontinuous Percoll (Sigma 
Chemical Company, St. Louis, MO) density gradient was prepared in sterile and nonpyrogenic 
0.15M NaCl solution, which was precooled at 4°C.  The Percoll solution was layered (3 ml per 
concentration) in 2 sterile 15 ml Fisher disposable centrifuge tubes without disturbing the 
gradients.  One ml of hemocyte suspension was aseptically layered on top of each preformed 
Percoll discontinuous gradient, and the tubes were centrifuged in the swinging bucket centrifuge 
at 3,500 x g for 20 minutes at 10°C.  The resulting hemocyte bands (band 1, 2, and 3) were 
individually and aseptically collected.  The cells were further diluted and washed in sterile 
0.15M NaCl, to prevent the formation of another gradient, and they were centrifuged at 1,200 x g 
for 10 minutes at 10°C.  The cells in band 1 were usually resuspended and diluted in TNM-FH 
insect medium to a concentration of around 5.0 to 7.0 x 106 cells ml-1.  Bands 2 and 3, due to 
usually low recovery rates, were diluted in 0.5 ml TNM-FH insect medium to a concentration of 
between 20 to 50 x 104 cells ml-1.  The hemocyte types present in each gradient fraction after 
resuspension were identified by examination under phase contrast optics.  The hemocytes were 
counted, and they were prepared and used for the standard binding assays.  
 
Confocal Laser Scanning Fluorescence Microscopy 
 A mixed population of P. clarkii hemocytes was double immunolabeled, as described in 
the standard binding assays, with MBSA-biotin, ARITC, and FITC-LPS.  A Leica confocal laser 
scanning microscope (CLSM) was used to obtain images of these cells.  The CLSM was 
equipped with 2 different lasers: an Argon ion laser emitting at 488 nm to excite FITC, and a 
HeNe laser emitting at 543 nm to excite ARITC.  The same double immunolabeled hemocytes 
were studied in 2 ways: 1) by sequential excitation with each laser on, and 2) by superposition of 
the same optical section images that were obtained from the sequential excitation of the cells 
with each laser on.  The superposition of the 2 images resulted in a combined 2-color FITC-
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ARITC image of the hemocyte surface.  The FITC signal (520 nm emission wavelength) was 
displayed on the monitor in the pseudo-color green.  The ARITC signal (572 nm emission 
wavelength) was displayed in pseudo-red.  A 200x magnification was enlarged 8 times on the 
monitor, resulting in a total 1,600x magnification of the recorded image. 
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CHAPTER 3 
RESULTS 
 
The Best Concentration of FITC-LPS Required for Binding to Procambarus clarkii Hemocytes 
 To ascertain the best concentration of FITC-LPS required for binding to potential LPS 
receptors on the surface of P. clarkii hemocytes, a series of 2 experiments, in which the 
concentration of ligand varied over a wide range, was performed.  The results indicate 5 µg ml-1 
FITC-LPS to be the best concentration of those tested (Table 1).  This concentration yielded an 
average 7.0% of fluorescent cells.  When the concentration of the exogenous fluorescent probe 
conjugated to LPS was below 5 µg ml-1, it was difficult to determine if the observed fluorescence 
signal was obtained from the autofluorescence of hemocytes or from the FITC-LPS bound to the 
cell surface.  In this case, the percent of fluorescent cells dropped to an average of 3%.  
Increasing the concentration of FITC-LPS above 5 µg ml-1 yielded no detectable increase in the 
percent of fluorescent cells.  
 
The Best Concentration of SFITC and ARITC Required for Binding to MBSA-Biotin Labeled 
Procambarus clarkii Hemocytes 
 A series of 2 experiments per fluorescent probe was performed to ascertain the best 
concentrations of SFITC and ARITC required for binding to P. clarkii hemocytes that were 
initially exposed to MBSA-biotin (1µgml-1).  The concentrations of these ligands varied over a 
wide range.  The results in Table 2 indicate 1 µg ml-1 SFITC to be the best concentration of those 
tested, yielding an average 9.8% of fluorescent cells.  Increasing the concentration of the SFITC 
exogenous fluorescent probe above 1 µg ml-1 yielded no significant increase in the percent of 
fluorescent cells that displayed distinct green granular fluorescence.  A SFITC concentration 
below 1 µg ml-1 was not tested.     
 The best concentration from those tested of ARITC, which was required for binding to 
MBSA-biotin labeled hemocytes, was 5 µg ml-1 (Table 3).  This concentration yielded an 
average 5.9% of fluorescent cells.  When the concentration of the ARITC was below this level, 
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Table 1.  The Best Concentration of FITC-LPS Required for Binding to Procambarus clarkii Hemocytes 
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2    Avg.+S.E.M. 
 
Control (0.15M NaCl)     0  0    0    2282 
 
FITC-LPS (1 µg ml-1)     3.3  2.9    3.1+0.20   2505 
 
FITC-LPS (2.5 µg ml-1)    3.5  2.5    3.0+0.50   3157 
 
FITC-LPS (5 µg ml-1)     7.1  6.9    7.0+0.10   2780  
 
FITC-LPS (10 µg ml-1)    6.8  7.0    6.9+0.10   2718 
 
FITC-LPS (15 µg ml-1)    6.1  6.8    6.5+0.35   3021  
 
FITC-LPS (20 µg ml-1)    6.4  7.4    6.9+0.50   2864  
 
 
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration 
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Table 2.  The Best Concentration of SFITC Required for Binding to MBSA-Biotin Labeled Procambarus clarkii Hemocytes  
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2    Avg.+S.E.M. 
 
Control (1 µg ml-1 BSA)    0   0    0    2499 
 
SFITC (1 µg ml-1)     10.3  9.3    9.8 + 0.50   3033 
  
SFITC (2.5 µg ml-1)     9.8  8.7    9.3 + 0.55   2455 
 
SFITC (5 µg ml-1)     9.6  9.6    9.6      2422 
 
SFITC (10 µg ml-1)     8.5  9.6    9.1 + 0.55   2210 
    
SFITC (15 µg ml-1)     10.9  10.6    10.8 + 0.15   2131 
 
SFITC (20 µg ml-1)     9.9  9.9    9.9    2898 
 
 
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration  
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Table 3.  The Best Concentration of ARITC Required for Binding to MBSA-Biotin Labeled Procambarus clarkii Hemocytes 
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp.1  Exp. 2    Avg.+S.E.M. 
 
Control (1 µg ml-1 BSA)    0  0    0    3348  
 
ARITC (1 µg ml-1)     3.1  3.9    3.5 + 0.40   2875 
         
ARITC (2.5 µg ml-1)     2.3  3.7    3.0 + 0.7   3639 
 
ARITC (5 µg ml-1)     5.7  6.0    5.9 + 0.15   3326 
 
ARITC (10 µg ml-1)     4.9  6.5    5.7 + 0.80   3683 
 
ARITC (15 µg ml-1)     4.6  5.8    5.2 + 0.60   3558 
 
ARITC (20 µg ml-1)     5.1  6.5    5.8 + 0.70   3407 
 
 
a  Cells displaying red and distinct granular fluorescence at 572 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration 
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the fluorescent cells became more difficult to count.  The percent of fluorescent cells 
dropped to an average of 3% and 3.5% at 1 µg ml-1 and 2.5 µg ml-1, respectively.  An 
ARITC concentration below 1 µg ml-1 was not tested.  Increasing the concentration of 
ARITC above 5 µg ml-1 yielded no significant increase in the percent of fluorescent cells 
that displayed distinct red granular fluorescence.  The best ligand concentrations were 
used thereafter in every experiment.  
  
Effect of LPS on the Observed Number of Fluorescent Procambarus clarkii Hemocytes 
Inhibition assays in a series of 3 experiments were used to analyze the inhibitory 
potency of LPS from the smooth lipolysaccharide of E. coli, serotype 0111:B4, on the 
observed number of fluorescent P. clarkii hemocytes.  The cells were subsequently 
incubated with FITC-LPS and with MBSA-biotin conjugated to ARITC.  The LPS 
portion of FITC-LPS was also prepared from the smooth lipopolysaccharide of E. coli, 
serotype 0111:B4. 
Hemocytes adhered to glass coverslips and fixed in methanol were incubated with 
various concentrations of LPS, and binding was allowed to occur for 30 minutes prior 
to FITC-LPS presentation.  As a control, 0.15M NaCl was added to hemocytes, and no 
fluorescent cells above the level of autofluorescence were detected.  As shown in Table 
4, LPS concentrations of 1.25 µg ml-1, 2.5 µg ml-1 and 5 µg ml-1 caused a 38% decrease 
in the observed number of fluorescent hemocytes.  A nearly 73% reduction in the 
observed number of fluorescent hemocytes was achieved by concentrations between 10 
and 40 µg ml-1 LPS.     
 In contrast, similar LPS concentrations were ineffective in decreasing the number 
of hemocytes that bound MBSA-biotin and, subsequently, ARITC (Table 5).  The 
percentage of fluorescent cells only fluctuated between 7.8-9.3%.  As a control, 
hemocytes were incubated with 0.15M NaCl, followed by BSA and ARITC, and no 
fluorescent cells above the level of autofluorescence were detected.  Figure 1 graphically 
summarizes these results.  It indirectly indicates, based on the observed percentage of 
fluorescent cells, that whereas LPS effectively inhibited the binding of FITC-LPS to P. 
clarkii hemocytes, it had no effect on the binding of the MBSA-biotin to these cells.  
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Table 4.  Effect of Different LPS Concentrations on the Observed Number of Fluorescent Procambarus clarkii Hemocytes Presented 
with FITC-LPS 
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2  Exp. 3   Avg.+S.E.M. 
 
Control (0.15M NaCl)   0  0  0   0    2521 
 
Control (5 µg ml-1 FITC-LPS)  6.8  5.5  6.2   6.2 + 0.38   1697          
 
LPS (1.25 µg ml-1)    4.0  3.5  4.1   3.9 + 0.19   2581 
 
LPS (2.5 µg ml-1)    3.9  3.5  3.9   3.8 + 0.13   2465 
 
LPS (5 µg ml-1)    3.9  3.4  4.5   3.9 + 0.32   2258 
 
LPS (10 µg ml-1)    1.5  1.2  2.0   1.6 + 0.23   2693 
   
LPS (20 µg ml-1)    2.2  1.6  2.0   1.9 + 0.18   3409   
         
LPS (40 µg ml-1)    1.6  1.7  2.0   1.8 + 0.12    3338 
 
 
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration  
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Table 5.  Effect of Different LPS Concentrations on the Observed Number of Fluorescent Procambarus clarkii Hemocytes Presented 
with MBSA-Biotin and ARITC  
   
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2  Exp. 3   Avg.+S.E.M. 
 
Control (1 µg ml-1 BSA)   0  0  0   0    2984 
 
Control (1 µg ml-1 MBSA-biotin)  7.7  10.1  8.3   8.7 + 0.72   2587 
 
LPS (1.25 µg ml-1)    8.1  10.0  8.4   8.8 + 0.59   2841 
 
LPS (2.5 µg ml-1)    7.5  9.8  8.1   8.5 + 0.69   2965 
 
LPS (5 µg ml-1)    8.8  8.8  7.7   8.4 + 0.37   2672 
 
LPS (10 µg ml-1)    8.6  10.3  8.5   9.1 + 0.58   2776 
 
LPS (20 µg ml-1)    6.5  8.2  8.8   7.8 + 0.69   2260 
 
LPS (40 µg ml-1)    9.2  9.6  9.2   9.3 + 0.13   2994 
 
 
a  Cells displaying red and distinct granular fluorescence at 572 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration
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Figure 1.  Effect of LPS on the Observed Number of Fluorescent Procambarus clarkii 
Hemocytes.  
 
LPS produced a concentration dependent decrease in the observed number of fluorescent 
hemocytes when incubated with the cells for 30 minutes prior to FITC-LPS () 
presentation.  Incubation with LPS for 30 minutes was ineffective in decreasing the 
percentage of fluorescent cells, and, therefore, in decreasing the number of hemocytes 
that subsequently bound MBSA-biotin and ARITC (z).  Error bars are missing, because 
the length of the error bar is less than the width of the point.  * Asterisks and + crosses 
indicate that the mean percentage of fluorescent hemocytes obtained for each 
concentration of inhibitor used is significantly different, at p < 0.05, from the mean 
percentage of fluorescent hemocytes of the control, which was not presented with the 
inhibitory LPS ligand (paired t test).  * Asterisks denote groups that are not significantly 
different from one another, but that are significantly different from groups marked with  + 
crosses (2-way ANOVA followed by LSD multiple comparisons test).  Similarly, + 
crosses denote groups that are not significantly different from one another, but that are 
significantly different from the groups marked with * asterisks.  An LSD value smaller 
than the difference between group means, an F-ratio >> 1and a p value < 0.05 indicated 
significant difference among group means.        
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Effect of Mannan on the Observed Number of Fluorescent Procambarus clarkii 
Hemocytes 
 Inhibition assays in a series of 3 experiments were used to analyze the inhibitory 
potency of mannan from S. cerevisiae on the observed number of fluorescent P.  clarkii 
hemocytes.  These cells were presented with FITC-LPS and with the MBSA-biotin 
subsequently conjugated to SFITC.    
Various concentrations of mannan were layered on top of hemocytes adhered to 
glass coverslips and fixed in methanol, and binding was allowed to occur for 30 minutes 
prior to FITC-LPS presentation.  The results in Table 6 indicate that even a high 
concentration of 150 µg ml-1 mannan was ineffective in decreasing the observed number 
of fluorescent hemocytes.  The percentage of fluorescent cells was nearly identical to that 
of the positive control (i.e. 7.9%).  As a control, 0.15M NaCl was added to hemocytes, 
and no fluorescent cells above the level of autofluorescence were detected.          
 Similarly, when the same mannan concentrations were layered on top of 
hemocytes and binding was allowed to occur for 30 minutes prior to MBSA-biotin 
followed by SFITC presentation, the percentage of fluorescent hemocytes remained 
constant.  It fluctuated between only 8.4% and 10% (Table 7).  As a control, hemocytes 
were incubated with 0.15M NaCl, BSA conjugate and SFITC.  No fluorescent cells 
above the level of autofluorescence were detected in the control. Mannan concentrations 
in the nanogram ml-1 and picogram ml-1 range were also used as inhibitory ligands for 
MBSA-biotin (data not shown).  However, they were ineffective in decreasing the 
observed percentage of fluorescent cells. The results in Tables 6 and 7 are graphically 
summarized in Figure 2.  These results indirectly indicate, based on the observed 
percentage of fluorescent cells, that mannan had no inhibitory effect on the binding of the 
FITC-LPS or the MBSA-biotin ligands to P. clarkii hemocytes.   
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Table 6.  Effect of Different Mannan Concentrations on the Observed Number of Fluorescent Procambarus clarkii Hemocytes 
Presented with FITC-LPS 
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2  Exp. 3   Avg.+S.E.M. 
 
Control (0.15M NaCl)   0  0  0   0    2582 
          
Control (5 µg ml-1 FITC-LPS)  8.2  7.1  8.3   7.9 + 0.38   2107         
 
Mannan (1 µg ml-1)    8.5  6.2  7.8          7.5 + 0.68   2141 
             
 Mannan (10 µg ml-1)    7.4  7.9  8.4          7.9 + 0.29   2467      
     
Mannan (25 µg ml-1)    7.2  7.4  6.7   7.1 + 0.21     2903   
 
Mannan (50 µg ml-1)    6.8  7.3  8.2          7.4 + 0.41   2447 
       
Mannan (100 µg ml-1)    6.6  8.4  8.0          7.7 + 0.55   2397 
 
Mannan (150 µg ml-1)    7.0  8.5  7.5   7.7 + 0.44   2731  
 
 
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration 
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Table 7.  Effect of Different Mannan Concentrations on the Observed Number of Fluorescent Procambarus clarkii Hemocytes 
Presented with MBSA-Biotin and SFITC  
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2  Exp. 3   Avg.+S.E.M. 
 
Control (1 µg ml-1 BSA)   0  0  0   0    1587 
 
Control (1 µg ml-1 MBSA-biotin)  11.5  8.6  9.2   9.8 + 0.88   1422             
 
Mannan  (1 µg ml-1)    9.6  7.9  8.0   8.5 + 0.55   2047          
 
Mannan  (10 µg ml-1)    8.8  7.8  8.7   8.4 + 0.32   2224 
 
Mannan  (25 µg ml-1)    10.8  6.7  9.4   9.0 + 1.20   1470 
 
Mannan  (50 µg ml-1)    11.9  8.0  10.2   10.0 + 1.13   1198 
 
Mannan  (100 µg ml-1)   10.6  8.0  8.0   8.9 + 0.87   1090   
 
Mannan  (125 µg ml-1)   9.8  7.7  9.6   9.0 + 0.67   1442  
 
 
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration 
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Figure 2.  Effect of Mannan on the Observed Number of Fluorescent Procambarus 
clarkii Hemocytes.   
 
Incubation of hemocytes with mannan for 30 minutes prior to FITC-LPS presentation 
(), and prior to MBSA-biotin followed by SFITC presentation  (z) produced no 
significant decrease, at p > 0.05, in the mean percent of fluorescent hemocytes when 
compared with the mean percent of fluorescent hemocytes of the controls that were not 
presented with mannan (paired t test).  Error bars are missing, because the length of the 
error bar is less than the width of the point.   
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Effect of Horseradish Peroxidase on the Observed Number of Fluorescent Procambarus 
clarkii Hemocytes 
 The inhibitory potency of various concentrations of horseradish peroxidase on the 
observed number of fluorescent P.  clarkii hemocytes incubated with FITC-LPS was 
tested in a series of 3 experiments (Table 8).  This glycoprotein appears to be an 
ineffective antagonist of the FITC-LPS ligand because the percentage of fluorescent 
hemocytes detected for each inhibitory assay concentration was similar to that of the 
positive control (i.e. 6.5% fluorescent cells).  As a control, 0.15M NaCl was added to 
hemocytes.  No fluorescent cells above the level of autofluorescence were detected in the 
control.           
 In contrast, horseradish peroxidase at concentrations between 10 and 100 µg ml-1 
decreased by 60% the number of fluorescent hemocytes exposed to MBSA-biotin and 
SFITC (Table 9).  A concentration of 1 µg ml-1 horseradish peroxidase did not result in a 
reduction in the observed number of fluorescent hemocytes.  As a control, hemocytes 
were incubated with 0.15M NaCl, BSA conjugate and SFITC.  No fluorescent cells 
above the level of autofluorescence were detected in the control.  These results are 
graphically summarized in Figure 3. 
 A comparison of Figures 1, 2, and 3, as well as Tables 4 – 9, indicates that 
whereas LPS effectively reduced the number of fluorescent hemocytes by 38% at low 
concentrations and by nearly 73% at higher concentrations, it had no effect on the 
binding of MBSA-biotin to hemocytes.  LPS was, therefore, an effective inhibitor of 
FITC-LPS binding to these cells.  In contrast, horseradish peroxidase was a potent 
antagonist for the binding of MBSA-biotin to hemocytes, decreasing by nearly 60% the 
number of fluorescent cells.  Horseradish peroxidase failed to inhibit the binding of 
FITC-LPS to hemocytes because it had no effect on the observed percentage of 
fluorescent cells. Mannan had no inhibitory effect on either ligand.  
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Table 8.  Effect of Different Horseradish Peroxidase Concentrations on the Observed Number of Fluorescent Procambarus clarkii 
Hemocytes Presented with FITC-LPS 
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2  Exp. 3   Avg.+S.E.M. 
 
Control (0.15M NaCl)   0  0  0   0    2782    
      
Control (5 µg ml-1 FITC-LPS)    6.7  6.8  5.9   6.5 + 0.28   3018 
 
HRP  (1 µg ml-1)     6.3  5.8  6.8   6.3 + 0.29   3029 
   
HRP  (10 µg ml-1)    7.4  7.0  7.2   7.2 + 0.12   2680 
     
HRP  (25 µg ml-1)     7.9  6.6     7.4   7.3 + 0.38   2559 
                         
HRP  (50 µg ml-1)    7.8  7.2  8.1     7.7 + 0.26   2861   
              
HRP  (100 µg ml-1)    6.3  7.6  6.3   6.7 + 0.43   2986 
 
 
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration  
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Table 9.  Effect of Different Horseradish Peroxidase Concentrations on the Observed Number of Fluorescent Procambarus clarkii 
Hemocytes Presented with MBSA-Biotin and SFITC  
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2  Exp. 3   Avg.+S.E.M. 
 
Control (1 µg ml-1 BSA)   0  0  0   0    2522 
 
Control (1 µg ml-1 MBSA-biotin)  6.2  8.4  8.6   7.7 + 0.77   2569 
 
HRP (1 µg ml-1)    5.5  7.3  7.6   6.8 + 0.66    2326 
             
HRP  (10 µg ml-1)    2.2  3.4  4.3   3.3 + 0.61   2595 
 
HRP  (25 µg ml-1)    2.8  2.6  2.7   2.7 + 0.06   3105 
 
HRP  (50 µg ml-1)    3.2  3.7  3.0   3.3 + 0.21   2426 
                        
HRP  (100 µg ml-1)    2.1  2.3  3.4   2.6 + 0.40    2604 
 
 
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the binding assays were performed as described in 
Materials and Methods 
b  n=average number of total cells counted per individual assay concentration  
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Figure 3.  Effect of Horseradish Peroxidase on the Observed Number of Fluorescent 
Procambarus clarkii Hemocytes.  
 
Incubation with horseradish peroxidase for 30 minutes, prior to FITC-LPS presentation 
(), was ineffective in decreasing the percent of fluorescent hemocytes.  In contrast, 
horseradish peroxidase produced a concentration dependent decrease in the percent of 
fluorescent hemocytes when incubated with the cells for 30 minutes prior to MBSA-
biotin followed by SFITC presentation (z).  Error bars are missing, because the length of 
the error bar is less than the width of the point.  *Asterisks indicate that the mean 
percentage of fluorescent hemocytes obtained for each concentration of inhibitor used is 
significantly different, at p < 0.05, from the mean percentage of fluorescent hemocytes of 
the control that was not presented with the inhibitory ligand (paired t test).   
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Enrichment of Procambarus clarkii Hemocyte Subpopulations Followed by FITC-LPS, 
MBSA-Biotin and SFITC Presentation 
Hemocyte subpopulations were isolated and enriched using a modification of a 
standard technique previously reported for marine and freshwater crustaceans, which 
employs a 40%, 50%, and 60% discontinuous Percoll gradient (14,15), in order to 
determine which hemocyte subpopulation is responsible for binding to LPS and to 
MBSA-biotin.  The morphologically enriched but not pure cell subpopulations included 
the hyaline, semigranular, and granular hemocytes collected from band 1, band 2, and 
band 3, respectively.  The enriched hemocytes were allowed to adhere to glass coverslips, 
and they were fixed in methanol prior to ligand presentation. 
In a series of 3 experiments, the enriched hemocyte subpopulations and a mixed 
hemocyte population were incubated with FITC-LPS and with 0.15M NaCl as the control 
(Table 10).  No fluorescent cells above the level of autofluorescence were detected in the 
control.  The average percentage of fluorescent cells in the mixed hemocyte population 
was 6.8%.  The hyaline cells constituted the predominant hemocyte type of band 1.  The 
0.4% of fluorescent cells obtained from this band consisted entirely of hemocytes with 
cytoplasmic granules.  These hemocytes were somehow prevented from reaching the 
50% or 60% discontinuous Percoll gradient interface or were accidentally introduced as 
contaminants during the collection procedure.  Band 2 consisted predominantly of 
semigranular hemocytes.  These cells displayed the typical fusiform morphology and 
contained a variable number of small granules.  The 4% of fluorescent cells detected in 
this band following FITC-LPS presentation consisted, once again, of apparently granular 
cells.  These hemocytes were shielded by other cells from reaching the 60% 
discontinuous Percoll gradient interface, or were introduced as contaminants during the 
collection procedure.  Lastly, band 3 contained mostly granular hemocytes, some 
semigranular cells, and some very small and dense cellular entities that were not 
observed prior to performing the discontinuous Percoll gradient enrichment procedure.  
These cellular entities could, indeed, be the nuclei of lysed hemocytes.  A comparison of 
the percentage of fluorescent cells obtained from this band with that of the mixed 
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Table 10.  Binding of FITC-LPS to Enriched Hemocytes of Procambarus clarkii 
 
 
Treatment   Cell  Predominant   %Fluorescent Cellsa     nb  
    Band  Hemocyte 
      Type  Exp.1  Exp.2  Exp.3  Avg.+S.E.M. 
 
Control (0.15M NaCl)     0  0  0  0   1953 
   ⇒ Mixed  H1,SG2,G3  
FITC-LPS (5 µg ml-1)      7.5  6.5  6.5  6.8 + 0.33  2396 
 
 
Control (0.15M NaCl)     0  0  0  0   2192 
   ⇒ 1  H 
FITC-LPS (5 µg ml-1)      0.3  0.4  0.4  0.4 + 0.03  2479 
 
 
Control       0  0  0  0   1349 
   ⇒ 2  SG 
FITC-LPS (5 µg ml-1)      1.8  2.7  7.6  4.0 + 1.80  1251 
 
 
Control       0  0  0  0   1129 
   ⇒ 3  G 
FITC-LPS (5 µg ml-1)      20.2  25.7  26.4  24.1 + 1.96  1111 
 
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the enrichment of hemocyte subpopulations 
[hyaline hemocytes (H1), semigranular hemocytes (SG2), and granular hemocytes (G3)] and the binding assays were performed as 
described in Materials and Methods 
b  n=average number of total cells counted per individual assay concentration
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hemocyte population indicates that the granular cells that are able to bind the ligand have 
been enriched about 3.5 times in the 60% discontinuous Percoll gradient portion that lay 
near the bottom of the centrifuge tube.  These results indicate the possible presence of a 
LPS recognition system associated with a subpopulation of P. clarkii granular 
hemocytes.  This recognition system mediates the binding of these cells to LPS.  
 Table 11 shows the results obtained from a series of 3 experiments in which the 
enriched hemocyte subpopulations and a mixed hemocyte population were presented 
with MBSA-biotin followed by SFITC and with BSA conjugate followed by SFITC as 
the control.  No fluorescent cells above the level of autofluorescence were detected in the 
control.  The average percentage of fluorescent cells in the mixed hemocyte population 
was 5.1%.  The hyaline cells constituted the predominant hemocyte type of Band 1.  The 
0.1% of fluorescent cells obtained from this band consisted of hemocytes containing 
cytoplasmic granules.  These cells were somehow prevented from reaching the 50% or 
60% discontinuous Percoll gradient interface or were introduced accidentally as 
contaminants during the collection procedure.  Band 2 consisted predominantly of  
semigranular hemocytes.  These cells displayed the typical fusiform morphology and 
contained a variable number of small granules.  The average 4.1% of fluorescent cells 
detected in this band, following MBSA-biotin and SFITC presentation, also appeared to 
consist of contaminating granular cells.  Band 3 was composed of mostly granular and 
some semigranular hemocytes.  A comparison of the percentage of fluorescent cells 
obtained from this band with that of the mixed hemocyte population, following MBSA-
biotin and SFITC presentation, indicates that the granular cells that are able to bind the 
ligand have been enriched about 4 times in the 60% discontinuous Percoll gradient 
portion that lay near the bottom of the centrifuge tube.   
Figure 4 graphically summarizes the results for the binding of the 2 ligands to 
enriched subpopulations of hemocytes.  It indicates the possible presence of 2 recognition 
systems associated with a subpopulation of P. clarkii granular hemocytes, which mediate 
the binding of LPS and mannose to these cells.   
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Table 11.  Binding of MBSA-Biotin and SFITC to Enriched Hemocytes of Procambarus clarkii 
Treatment   Cell  Predominant   %Fluorescent Cellsa     nb  
    Band  Hemocyte 
      Type  Exp.1  Exp.2  Exp.3  Avg.+S.E.M. 
 
Control (1 µg ml-1 BSA)     0  0  0  0   2272  
   ⇒ Mixed  H1,SG2,G3  
MBSA-biotin (1 µg ml-1)     4.1  6.4  4.9  5.1 + 0.67  2284 
 
        
Control (1 µg ml-1 BSA)     0  0  0  0   2975 
   ⇒ 1  H 
MBSA-biotin (1 µg ml-1)     0.04  0.1  0.2  0.1 + 0.05  3112 
 
        
Control (1 µg ml-1 BSA)     0  0  0  0   1223 
   ⇒ 2  SG 
MBSA-biotin (1 µg ml-1)     1.0  4.8  6.6  4.1 + 1.65  1747 
      
 
Control (1 µg ml-1 BSA)     0  0  0  0   1536 
   ⇒ 3  G 
MBSA-biotin (1 µg ml-1)     15.2  19.8  23.7  19.6 + 2.46  1249 
        
a  Cells displaying green and distinct granular fluorescence at 520 nm wavelength; the enrichment of hemocyte subpopulations 
[hyaline hemocytes (H1), semigranular hemocytes (SG2), and granular hemocytes (G3)] and the binding assays were performed as 
described in Materials and Methods 
b  n=average number of total cells counted per individual assay concentration
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Figure 4.  Enrichment of Procambarus clarkii Hemocyte Subpopulations Followed by 
FITC-LPS and MBSA-Biotin + SFITC Binding.   
 
The bars indicate the mean percent of fluorescent hemocytes observed in a mixed 
hemocyte population, and in morphologically enriched but not pure hyaline, 
semigranular, and granular hemocyte subpopulations, obtained from Band 1, Band 2, and 
Band 3, respectively, of the discontinous Percoll gradient.  The fluorescent hemocytes 
that bound LPS (gray bars) and the MBSA-biotin conjugate (white bars), both conjugated 
to fluorescent probes, appear to have been enriched about 3 to 4 times when compared to 
the mean percent of fluorescent hemocytes observed in the mixed population.   
46 
Double Immunolabeling of Procambarus clarkii Hemocytes with MBSA-Biotin, ARITC 
and FITC-LPS and Laser Scanning Confocal Microscopy 
 To ascertain whether the LPS and mannose specific recognition systems are 
present on the surface of similar or disparate subpopulations of granular hemocytes, 
mixed cells were double immunolabeled by incubation for 30 minutes at a time with 
MBSA-biotin, ARITC, and FITC-LPS.  As a control, hemocytes were incubated with the 
BSA conjugate and with 0.15M NaCl.  No fluorescent cells above the level of 
autofluorescence were detected in the control.  The results in Table 12 indicate that an 
average of 7.6% of fluorescent cells was detected.  These cells were granular hemocytes 
that displayed both green and red distinct granular fluorescence at 520 nm and 572 nm 
emission wavelengths, respectively.  Hemocytes that displayed only green or only red 
fluorescence were not observed.  These results indicate that the same subpopulation of 
granular hemocytes binds to both LPS and mannose.  
A Leica confocal laser scanning microscope was then used to obtain images of the 
double immunolabeled cells from a mixed hemocyte population.  The same double 
immunolabeled hemocytes were studied in 2 ways: 1) by sequential excitation with an 
Argon ion laser emitting at 488 nm to excite the FITC bound to LPS (Figure 5 A) and 
with a HeNe laser emitting at 543 nm to excite the ARITC conjugated to MBSA-biotin 
(Figure 5 B), and 2) by superposition of both individual images (Figure 5 C).  The 
superposition of the 2 images resulted in a combined 2-color FITC-ARITC image of the 
hemocyte surface.   Again, granular hemocytes appeared to display both green and red 
fluorescence at 520 nm and 572 nm emission wavelengths, respectively.  Hemocytes that 
displayed only green or only red fluorescence were not observed.  The images give 
additional support to the specificity of the immunostaining.  They show both the FITC-
LPS and the MBSA-biotin conjugated to ARITC bound to the surface of the same 
granular hemocytes, possibly via 2 different and specific recognition systems (Figure 5).
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Table 12.  Double Immunolabeling of Procambarus clarkii Hemocytes with MBSA-Biotin, ARITC and FITC-LPS   
 
 
Treatment        %Fluorescent Cellsa      nb 
 
Exp. 1  Exp. 2  Exp. 3   Avg.+S.E.M. 
 
Control (1 µg ml-1 BSA +  
5 µg ml-1 ARITC +    
0.15M NaCl)     0  0  0   0    3247 
    
 
MBSA-biotin  (1 µg ml-1) + ARITC 
(5 µg ml-1) + FITC-LPS (1 µg ml-1)  8.4  6.6  7.7   7.6 + 0.52   3056  
 
 
a  Cells displaying both green and red distinct granular fluorescence at 520 nm and 572 nm wavelengths, respectively; the binding 
assays were performed as described in Materials and Methods 
b  n=average number of total cells counted per individual assay concentration 
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A B  C 
 
Figure 5.  Confocal Images of Procambarus clarkii Hemocytes Double Immunolabeled with Both MBSA-Biotin + ARITC and FITC-
LPS (A-C).   
 
A 200x magnification was enlarged 8 times on the monitor, resulting in a total 1,600x magnification.  (A)  Image of granular cells in a 
mixed hemocyte population after excitation with the 488 nm laser (520 nm emission wavelength), indicating the specific binding of 
FITC-LPS to the hemocytes' surfaces.  (B)  Image of the same granular cells following excitation with the 543 nm laser (572 nm 
emission wavelength), showing the presence of ARITC conjugated to MBSA-biotin labeled hemocytes.  (C)  Picture of the granular 
hemocytes in (A) and (B) obtained by superimposing the previous 2 images of the same optical section.  Because hemocytes that 
displayed only pseudo-green or only pseudo-red fluorescence were not observed, this image shows the presence of both LPS and 
mannose recognition systems on the surface of the same granular hemocytes. 
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           CHAPTER 4 
DISCUSSION 
 
As in mammalian systems, invertebrate pattern recognition molecules sample the 
internal environment and have multiple functions that are responsible for the  
interrelated host immune activities of specific recognition and response (1,2,3).  
Although more primitive from an evolutionary perspective and devoid of antibody 
producing ability, the recognition of “non-self” molecules in invertebrates appears to be 
extremely efficient.  The proPO system released by semigranular and granular cells, 
following recognition by its endogenous proteins and their receptors, responds to 
picograms per liter of bacterial LPS, peptidoglycans, and fungal β-1,3-glucans (32).  In 
this study, LPS and mannose binding and inhibition assays were coupled to the isolation 
by buoyant density of morphologically enriched subpopulations of P. clarkii hemocytes, 
in order to establish the possible presence and localization of LPS and mannose receptors 
in this invertebrate species.   
First of all, the results indicate that LPS and MBSA-biotin (a neoglycoprotein), 
both conjugated to exogenous fluorescent probes, bind to a small percentage of 
hemocytes.  This percent ranges from about 6%-10% (Tables 1,2,3).  The conjugation of 
MBSA-biotin to streptavidin-fluorescein isothiocyanate and to avidin-rhodamine 
isothiocyanate could not significantly alter the results, since streptavidin has been 
reported to have a biotin-binding activity similar to that of avidin (37). 
Having a definable ligand specificity is one of the preliminary standards that 
suggests the presence of a receptor-mediated binding process (13).  The inhibition assays 
summarized in Figure 1 show that LPS concentrations of 10, 20, and 40 µg ml-1 caused 
an approximately 73% reduction in the number of observed fluorescent cells when FITC-
LPS was presented to the hemocytes.  Lower concentrations of the inhibitory ligand 
resulted in a 38% inhibitory potency.  These results indirectly indicate that LPS 
effectively inhibits the binding of FITC-LPS to hemocytes.   
The mannose receptor has been reported to bind to certain strains of LPS that 
have nonreducing terminal N-acetyl-D-glucosamine and D-mannoheptose residues 
present in their rough outer core polysaccharide (4,16).  However, the LPS used in this 
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study was purified from the smooth lipopolysaccharide of E. coli, serotype 0III:B4.  The 
polysaccharide side chains in the LPS from this organism do not contain mannose.  They 
have terminally located colitose residues that form the primary antigenic determinant of 
the polymer and mask the N-acetyl-D-glucosamine residues of the molecule (38).  As 
expected, and as indicated in Table 5 and Figure 1, various concentrations of LPS did not 
reduce the observed number of fluorescent cells when the hemocytes were presented with 
MBSA-biotin and ARITC.  These results indirectly indicate that LPS from E. coli, 
serotype 0III:B4, was an ineffective antagonist for the binding of the MBSA-biotin 
conjugate to hemocytes.  They provide evidence for the LPS specificity of one of these 
hemocyte recognition systems. 
Mannan is the principal antigen of yeast (15), and it has been shown to have a 
nearly complete inhibitory potency on the uptake of β-glucuronidase by macrophages 
(12).  However, it had no inhibitory activity on the binding to hemocytes of MBSA-biotin 
subsequently conjugated to SFITC because the percentage of fluorescent hemocytes 
remained constant (Table 7, Figure 2).  It is possible that, due to steric hindrance, the 
specific conformation of the purified mannan antigen could not be accommodated in 
vitro by the mannose recognition system of hemocytes.  Furthermore, it has been reported 
that invertebrate lectins display a stronger affinity for glycoprotein sugars than for 
polysaccharides (39).  
Horseradish peroxidase is a glycoprotein, which contains an 86% carbohydrate 
content that consists predominantly of mannose and glucosamine (14).  In contrast to 
mannan, horseradish peroxidase concentrations of 10, 25, 50, and 100 µg ml-1 achieved 
an almost 60% decrease in the number of fluorescent hemocytes that bound MBSA-
biotin and SFITC (Table 9).  It had no effect on the number of fluorescent hemocytes that 
bound FITC-LPS (Table 8).  These results indirectly suggest that horseradish peroxidase 
effectively inhibited the binding of MBSA-biotin to hemocytes (Figure 3).  They provide 
evidence for the possible mannose specificity of this hemocyte recognition system.  
However, other carbohydrate moieties of horseradish peroxidase beside mannose could 
have ligated to the hemocytes and prevented the binding of the MBSA-biotin conjugate.   
The hemocyte subpopulations were morphologically enriched by buoyant density 
(23,24) to ascertain which hemocyte subpopulation is responsible for binding to LPS and 
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to MBSA-biotin (Tables 10 and 11, Figure 4).  When compared to the other bands, the 
highest percent of fluorescent cells (24% for FITC-LPS, and 20% for MBSA-biotin and 
SFITC presentation) was found in Band 3.  This band was present in the 60% 
discontinuous Percoll gradient portion that lay near the bottom of the centrifuge tube, and 
it predominantly contained granular hemocytes.  In both sets of experiments, a 
comparison of the percentage of fluorescent cells obtained from Band 3 with that of the 
mixed hemocyte population indicates that the granular cells having the ability to bind the 
ligands have been enriched about 3 to 4 times in Band 3.  A subpopulation of granular 
hemocytes is apparently capable of binding to LPS and mannose.  The hyaline cells were 
the predominant cells in Band 1.  The extremely small percent of fluorescent cells 
obtained from this band consisted entirely of hemocytes with cytoplasmic granules.  Only 
4% of the hemocytes in Band 2 fluoresced, indicating the possible contamination of this 
band with granular hemocytes during the collection procedure.   
The cytoplasm of many hemocytes in Bands 2 and 3 appeared lysed and damaged, 
and autofluorescence derived from the granules was routinely observed in the control 
during excitation at 490 nm wavelength. Thus, the main problem to be overcome when 
counting fluorescent hemocytes was to differentiate between autofluorescence and 
specific immunofluorescence.  It is possible that the percentages of fluorescent 
hemocytes obtained for these 2 bands are lower than they should be because only 
hemocytes displaying intense green flourescence were considered positive.     
To determine if similar or disparate granular hemocytes contain the LPS- and 
mannose-specific recognition systems, mixed hemocytes were exposed for 30 minutes at 
a time to MBSA-biotin, ARITC, and FITC-LPS (Table 12). One P. clarkii hemocyte 
type, which seemed to have a round or slightly oval morphology and contained numerous 
large cytoplasmic granules, fluoresced both red and green when observed under 
fluorescence and confocal microscopy (Figure 5 A and B).  Both fluorescent probes were 
visible on the surface of these particular hemocytes (Figure 5 C).   Hemocytes that 
displayed only green or only red fluorescence were not observed, suggesting that this 
hemocyte subpopulation contains both the LPS and the mannose receptors on their 
surfaces.  
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Previous reports suggest that granular hemocytes, unlike semigranular hemocytes, 
are unable to degranulate in response to direct exposure to LPS and fungal cell wall 
molecules (1,17,28).  However, the preliminary evidence presented in this study points to 
the possible presence of 2 recognition systems associated with a subpopulation of 
granular hemocytes from the red swamp crayfish, P. clarkii.  These receptors specifically 
bind to both LPS and mannose, and they may be involved in triggering vital cellular and 
humoral defense mechanisms of this animal in response to a pathogenic challenge.  The 
isolation and purification, as well as the details of in vivo function, ligand interaction and 
cell-to-cell communication of these 2 invertebrate specific recognition systems await 
further investigation. 
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APPENDIX 
 
List of Formulas 
 
 
Crayfish Anticoagulant Buffer (23) 
 
0.14 M NaCl 
0.1 M Glucose 
30 mM Trisodium Citrate 
26 mM Citric Acid 
10 mM EDTA 
pH = 4.6 
Dissolved in double distilled H2O and filter sterilized 
TNM-FH Insect Medium 
 
Powdered cell culture medium dissolved to 51.2 mg ml-1 in sterile double distilled H2O 
and filter sterilized 
 
Crayfish Saline (24) 
 
0.2 M NaCl 
5.4 mM KCl 
10 mM CaCl2 
2.6 mM MgCl2 
2 mM NaHCO3 
pH 6.8 
Dissolved in double distilled H2O and autoclaved 
NaCl 
 
0.15 M NaCl made up in sterile double distilled H2O and autoclaved 
 
Glycine Saline Buffer (Immunofluorescence Mounting Medium) (36) 
 
14.0 g Glycine 
0.7 g NaOH 
17 g NaCl 
1 g Sodium azide 
Dissolved in 500 ml double distilled H2O, and made up to 1000 ml 
pH 8.6 
30 ml buffer mixed with 70 ml glycerol (30%) 
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